Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE5A | O76074 | 19/20 | 0.38 |
| ▸ | PDE3B | Q13370 | 3/20 | 0.38 |
| ▸ | PDE3A | Q14432 | 3/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 8/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 8/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.35 |
| ▸ | MTOR | P42345 | 1/20 | 0.35 |
| ▸ | PDE6C | P51160 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8047597 | 0.90 | PDE5A (0.38) | PDE5APDE3BPDE3AHDAC1HDAC6 | |
| SCHEMBL8042867 | 0.87 | KDM4E (0.33) | — | |
| SCHEMBL8050917 | 0.86 | PDE5A (0.44) | PDE5APDE3BPDE3AHDAC1HDAC6 | |
| SCHEMBL8045595 | 0.86 | PDE5A (0.41) | PDE5APDE3BPDE3AHDAC1HDAC6 | |
| SCHEMBL8049072 | 0.83 | PDE5A (0.48) | PDE5APDE3BPDE3AHDAC1HDAC6 | |
| SCHEMBL8047604 | 0.79 | PDE5A (0.42) | PDE5APDE3BPDE3AHDAC1HDAC6 | |
| SCHEMBL3993298 | 0.79 | PDE5A (0.44) | PDE5APDE3BPDE3AHDAC1HDAC6 | |
| SCHEMBL8045086 | 0.77 | PDE5A (0.47) | PDE5APDE3BPDE3AHDAC1HDAC6 | |
| SCHEMBL4136868 | 0.77 | PDE5A (0.44) | PDE5APDE3BPDE3AHDAC1HDAC6 | |
| SCHEMBL4117716 | 0.76 | SIGMAR1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009071707-A1 | NOVEL COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES | GALAPAGOS NV (BE) | 2009-06-11 | — | — | WO | disclosed |